Summit Therapeutics  logo
Summit Therapeutics SMMT
$ 19.01 3.2%

Quarterly report 2024-Q3
added 10-30-2024

report update icon

Summit Therapeutics Market Cap 2011-2024 | SMMT

As of November 25, 2024 Summit Therapeutics has a market cap of $ 11.8 B


The capitalization of a company is the product of the price of a share for the number of shares issued and listed. Market capitalization (Market Cap) is an important market indicator of the value of shares and the value of companies in general.[1]

Typically, market capitalization is divided into several categories: large cap (over $10 billion), mid cap ($2-10 billion), and small cap (less than $2 billion). Companies with large market capitalization are considered more stable and liquid, while companies with small market capitalization may have greater growth potential but also higher levels of risk.

Market Cap can also be used to compare different companies within an industry or market. For example, comparing the market capitalization of two companies can help determine which one is more valuable or promising for investment.

Annual Market Cap Summit Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.24 B 286 M 361 M 417 M 195 M 804 M 791 M 390 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.24 B 195 M 685 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.